InvestorsHub Logo
Followers 87
Posts 6766
Boards Moderated 1
Alias Born 09/18/2009

Re: pipette post# 34713

Monday, 12/20/2021 4:14:55 PM

Monday, December 20, 2021 4:14:55 PM

Post# of 43138
As a matter of fact, "On December 20, 2021, Novavax, Inc. (the “Company”) issued a press release announcing that the European Commission (the “EC”) granted the Company conditional marketing authorization for its Nuvaxovid™ COVID-19 Vaccine."

https://ih.advfn.com/stock-market/NASDAQ/novavax-NVAX/stock-news/86858298/current-report-filing-8-k
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.